Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of placebo and risperidone. Risperidone is an atypical (second-generation) antipsychotic medication used primarily to treat schizophrenia, bipolar disorder, and irritability associated with autism spectrum disorder. It works mainly by antagonizing dopamine D2 receptors and serotonin 5-HT2A receptors in the brain, leading to changes in neurotransmitter activity that help regulate mood, behavior, and thought processes. Placebo is an inert substance with no active pharmacological effect; it is commonly used as a control in clinical trials to assess the efficacy of active medications like risperidone[1][2][3][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on placebo + risperidone.